Gimbal Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$283K Hold
2,205
0.17% 41
2025
Q2
$267K Buy
2,205
+2
+0.1% +$225 0.16% 39
2025
Q1
$246K Hold
2,203
0.22% 35
2024
Q4
$214K Hold
2,203
0.18% 44
2024
Q3
$249K Sell
2,203
-43
-2% -$4.88K 0.16% 42
2024
Q2
$248K Buy
2,246
+3
+0.1% +$301 0.18% 38
2024
Q1
$217K Hold
2,243
0.18% 44
2023
Q4
$226K Buy
+2,243
New +$217K 0.23% 39

Other funds holding NVS

Gimbal Financial's NVS Position: Q3 2025 in Review

Gimbal Financial held its Novartis (NVS) position steady in Q3 2025 at 2,205 shares worth $283K. The position accounts for 0.17% of the portfolio, ranked #41.

Gimbal Financial first reported a position in NVS in Q4 2023 and has held it in 8 quarters since. 1,401 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Gimbal Financial held 2,205 shares of Novartis worth $283K as of Q3 2025.
  • Gimbal Financial left its Novartis share count unchanged in Q3 2025.
  • Novartis made up 0.17% of Gimbal Financial's portfolio in Q3 2025, its #41 holding.
  • Gimbal Financial first reported a position in Novartis in Q4 2023 and has held it in 8 quarters since.
  • 1,401 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Gimbal Financial's 13F filing for Q3 2025, filed 4 Nov 2025.